Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.
Recruiting
N/A
Interventional Study
Alzheimer's Disease (AD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 55 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 240 (estimated)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to determine how blood biomarker tests (ptau217 and ptau217/Aβ42) performed in primary care influence the patient trajectory in individuals with cognitive concerns. Participants will provide a blood sample for biomarker testing and undergo clinical assessments as part of diagnostic evaluation.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients between 55 and 85 years old who consult their PCP due to concerns about their cognitive status.
Exclusion Criteria:
* Comorbidities that would interfere with study cooperation or interpretability of study results (for instance substance abuse or cardiac, renal or he…
Contacts
No contact information available.